Shikonin inhibits the malignant progression of triple-negative breast cancer

ABSTRACT: To investigate the underlying mechanism of shikonin in TNBC, we performed high-throughput sequencing to screen differentially expressed genes 24 hours after shikonin treatment

ORGANISM(S): Homo sapiens

PROVIDER: GSE281168 | GEO | 2025/08/22

REPOSITORIES: GEO